MMSI Stock News & Analysis | Latest Updates

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enrollment of the first patient in the WRAP North America registry.

August 18, 2025Clinical Trials

Read more →

What Does the Market Think About Merit Medical Systems?

MMSI

June 9, 2025

Read more →

Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today

MMSI

May 28, 2025

Read more →

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $110

MMSI

May 23, 2025

Read more →

Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112

MMSI

May 21, 2025

Read more →

Wells Fargo Maintains Overweight on Merit Medical Systems, Raises Price Target to $108

MMSI

May 21, 2025

Read more →

Needham Reiterates Buy on Merit Medical Systems, Maintains $108 Price Target

MMSI

May 20, 2025

Read more →

Merit Medical Systems Lowers FY2025 Adj EPS Guidance from $3.29-$3.42 to $3.28-$3.41 vs $3.65 Est; Raises FY2025 Sales Guidance from $1.47B-$1.49B to $1.48B-$1.50B vs $1.48B Est

MMSI

May 20, 2025

Read more →

Merit Medical Systems Now Sees FY25 Net Sales Of $1.480B - $1.501B Vs Prior Guidance Range Of $1.470B - $1.490B; Now Expects FY25 Non-GAAP EPS Of $3.28-$3.41 Vs Prior Outlook Of $3.29-$3.42

MMSI

May 20, 2025

Read more →

Merit Medical Systems Acquires Biolife Delaware In $120M Merger Transaction

MMSI

May 20, 2025

Read more →

Here's How Much You Would Have Made Owning Merit Medical Systems Stock In The Last 15 Years

MMSI

May 19, 2025

Read more →

The Analyst Verdict: Merit Medical Systems In The Eyes Of 14 Experts

MMSI

May 15, 2025

Read more →

Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $108

MMSI

May 15, 2025

Read more →

Merit Medical Systems Receives Health Canada Regulatory Approval For Wrapsody Cell-Impermeable Endoprosthesis

MMSI

May 6, 2025

Read more →

Merit Medical Releases 12-Month Efficacy Results For Single-Arm Arteriovenous Graft Cohort Of WRAPSODY Arteriovenous Efficacy Trial

MMSI

May 5, 2025

Read more →

The Analyst Verdict: Merit Medical Systems In The Eyes Of 17 Experts

MMSI

April 25, 2025

Read more →

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $108

MMSI

April 25, 2025

Read more →

Raymond James Maintains Outperform on Merit Medical Systems, Lowers Price Target to $108

MMSI

April 25, 2025

Read more →

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $103

MMSI

April 25, 2025

Read more →

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $100

MMSI

April 25, 2025

Read more →

Baird Maintains Outperform on Merit Medical Systems, Lowers Price Target to $110

MMSI

April 25, 2025

Read more →

Merit Medical Systems Lowers FY2025 Adj EPS Guidance from $3.58-$3.70 to $3.29-$3.42 vs $3.65 Est; Affirms FY2025 Sales Guidance of $1.47B-$1.49B vs $1.48B Est

MMSI

April 24, 2025

Read more →

Merit Medical Systems Q1 Adj. EPS $0.86 Beats $0.75 Estimate, Sales $355.35M Beat $352.57M Estimate

MMSI

April 24, 2025

Read more →

Piper Sandler Maintains Overweight on Merit Medical Systems, Lowers Price Target to $112

MMSI

April 23, 2025

Read more →

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

MMSI

April 22, 2025

Read more →

US-China Trade Tensions Poses Risk To Merit Medical's $150 Million Revenue From China

MMSI

Merit Medical guides below consensus on FY25 EPS, projects up to $1.49 billion revenue, and faces tariff risks amid ongoing global manufacturing expansion.

April 11, 2025

Read more →

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $111 Price Target

MMSI

April 11, 2025

Read more →

Needham Reiterates Buy on Merit Medical Systems, Maintains $116 Price Target

MMSI

April 9, 2025

Read more →

How Do Investors Really Feel About Merit Medical Systems?

MMSI

April 2, 2025

Read more →

Assessing Merit Medical Systems: Insights From 12 Financial Analysts

MMSI

March 28, 2025

Read more →

JP Morgan Initiates Coverage On Merit Medical Systems with Overweight Rating, Announces Price Target of $120

MMSI

March 28, 2025

Read more →

Merit Medical Enrolls First Patient In PREEMIE Study

MMSI

March 10, 2025

Read more →

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $111

MMSI

February 26, 2025

Read more →

Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)

MMSI

February 26, 2025

Read more →

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $127

MMSI

February 26, 2025

Read more →

Wells Fargo Maintains Overweight on Merit Medical Systems, Lowers Price Target to $117

MMSI

February 26, 2025

Read more →

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $116

MMSI

February 26, 2025

Read more →

Merit Medical Sees FY25 Revenue $1.47B-$1.49B Vs $1.477B Estimate; Sees FY25 Adj. EPS $3.58-$3.70 Vs $3.74 Estimate

MMSI

February 25, 2025

Read more →

Merit Medical Systems Q4 2024 Adj EPS $0.93 Beats $0.83 Estimate, Sales $355.20M Beat $351.35M Estimate

MMSI

February 25, 2025

Read more →

Looking Into Merit Medical Systems's Recent Short Interest

MMSI

February 12, 2025

Read more →

Needham Reiterates Buy on Merit Medical Systems, Maintains $109 Price Target

MMSI

January 14, 2025

Read more →

Reported Earlier, Merit Medical Announces Preliminary 2024 Revenue Of $1.355B–$1.357B, A Rise Of 7.7%–7.9% YoY

MMSI

January 14, 2025

Read more →

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

MMSI

December 23, 2024

Read more →

Merit Medical Secures FDA Approval For WRAPSODY Cell-Impermeable Endoprosthesis, Extending Life-Saving Treatment For Dialysis Patients With U.S. Commercialization Set For 2025

MMSI

December 20, 2024

Read more →

Price Over Earnings Overview: Merit Medical Systems

MMSI

December 19, 2024

Read more →

How Is The Market Feeling About Merit Medical Systems?

MMSI

November 18, 2024

Read more →

Needham Reiterates Buy on Merit Medical Systems, Maintains $109 Price Target

MMSI

October 31, 2024

Read more →

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

MMSI

October 31, 2024

Read more →

Baird Maintains Outperform on Merit Medical Systems, Raises Price Target to $109

MMSI

October 31, 2024

Read more →

Merit Medical Launches basixSKY Inflation Device

MMSI

May 21, 2024

Read more →

MMSI News

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

What Does the Market Think About Merit Medical Systems?

Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $110

Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112

Wells Fargo Maintains Overweight on Merit Medical Systems, Raises Price Target to $108

Needham Reiterates Buy on Merit Medical Systems, Maintains $108 Price Target

Merit Medical Systems Lowers FY2025 Adj EPS Guidance from $3.29-$3.42 to $3.28-$3.41 vs $3.65 Est; Raises FY2025 Sales Guidance from $1.47B-$1.49B to $1.48B-$1.50B vs $1.48B Est

Merit Medical Systems Now Sees FY25 Net Sales Of $1.480B - $1.501B Vs Prior Guidance Range Of $1.470B - $1.490B; Now Expects FY25 Non-GAAP EPS Of $3.28-$3.41 Vs Prior Outlook Of $3.29-$3.42

Merit Medical Systems Acquires Biolife Delaware In $120M Merger Transaction

Here's How Much You Would Have Made Owning Merit Medical Systems Stock In The Last 15 Years

The Analyst Verdict: Merit Medical Systems In The Eyes Of 14 Experts

Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $108

Merit Medical Systems Receives Health Canada Regulatory Approval For Wrapsody Cell-Impermeable Endoprosthesis

Merit Medical Releases 12-Month Efficacy Results For Single-Arm Arteriovenous Graft Cohort Of WRAPSODY Arteriovenous Efficacy Trial

The Analyst Verdict: Merit Medical Systems In The Eyes Of 17 Experts

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $108

Raymond James Maintains Outperform on Merit Medical Systems, Lowers Price Target to $108

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $103

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $100

Baird Maintains Outperform on Merit Medical Systems, Lowers Price Target to $110

Merit Medical Systems Lowers FY2025 Adj EPS Guidance from $3.58-$3.70 to $3.29-$3.42 vs $3.65 Est; Affirms FY2025 Sales Guidance of $1.47B-$1.49B vs $1.48B Est

Merit Medical Systems Q1 Adj. EPS $0.86 Beats $0.75 Estimate, Sales $355.35M Beat $352.57M Estimate

Piper Sandler Maintains Overweight on Merit Medical Systems, Lowers Price Target to $112

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

US-China Trade Tensions Poses Risk To Merit Medical's $150 Million Revenue From China

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $111 Price Target

Needham Reiterates Buy on Merit Medical Systems, Maintains $116 Price Target

How Do Investors Really Feel About Merit Medical Systems?

Assessing Merit Medical Systems: Insights From 12 Financial Analysts

JP Morgan Initiates Coverage On Merit Medical Systems with Overweight Rating, Announces Price Target of $120

Merit Medical Enrolls First Patient In PREEMIE Study

Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $111

Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)

Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $127

Wells Fargo Maintains Overweight on Merit Medical Systems, Lowers Price Target to $117

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $116

Merit Medical Sees FY25 Revenue $1.47B-$1.49B Vs $1.477B Estimate; Sees FY25 Adj. EPS $3.58-$3.70 Vs $3.74 Estimate

Merit Medical Systems Q4 2024 Adj EPS $0.93 Beats $0.83 Estimate, Sales $355.20M Beat $351.35M Estimate

Looking Into Merit Medical Systems's Recent Short Interest

Needham Reiterates Buy on Merit Medical Systems, Maintains $109 Price Target

Reported Earlier, Merit Medical Announces Preliminary 2024 Revenue Of $1.355B–$1.357B, A Rise Of 7.7%–7.9% YoY

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

Merit Medical Secures FDA Approval For WRAPSODY Cell-Impermeable Endoprosthesis, Extending Life-Saving Treatment For Dialysis Patients With U.S. Commercialization Set For 2025

Price Over Earnings Overview: Merit Medical Systems

How Is The Market Feeling About Merit Medical Systems?

Needham Reiterates Buy on Merit Medical Systems, Maintains $109 Price Target

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

Baird Maintains Outperform on Merit Medical Systems, Raises Price Target to $109

Merit Medical Launches basixSKY Inflation Device